KansasHB 22182025–2026 Regular SessionHouse

Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

Sponsored By: Committee on Health and Human Services

Failed

house committee on health and human services

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Committee on Health and Human Services

    Affiliation unavailable

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Stricken from Calendar by Rule 1507

    2/19/2026House
  2. Committee of the Whole - Passed over and retain a place on the calendar

    2/18/2026House
  3. Committee Report recommending bill be passed as amended by House Committee on Health and Human Services

    1/28/2026House
  4. Hearing: Tuesday, February 11, 2025, 1:30 PM — Room 112-N

    2/11/2025House
  5. Introduced

    2/3/2025House
  6. Referred to House Committee on Health and Human Services

    2/3/2025House

Bill Text

  • As Amended by House Committee

  • As Introduced

Related Bills

Back to State Legislation